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administered was 140.9352.8 mg. Anticoagulation was assessed prior and during the
PCI using the activated clotting time (ACT) as a PD parameter. Serial blood samples
for bivalirudin PK were collected at baseline (pre-bolus), 5 min (post-bolus), end of
infusion, 10, 30 and 120 min post-infusion and analyzed by a validated LC/MS/MS
method (Frontage Labs, Shanghai). Plasma concentrations versus time data were
calculated by noncompartmental analysis using Phoenix WinNonlin Version 6.3
(Pharsight Corp, Sunnyvale, CA).
Results: Steady levels of bivalirudin were maintained during the infusion and rapidly
eliminated after the end of infusion with a half-life of 32 min. The meanSD values of
Cmax, Tmax, AUClast, t, CL and Vd were 60301247 ng/mL, 0.510.57 h,
6304.473554 h$ng/mL, 0.530.19 h (32 min), 25.68 13.78 L/h, 18.3 8.7 L,
respectively. The meanSD ACTs were 171.7 31 sec. at baseline and 428.8 135
sec. at 5 min after bivalirudin administration (P<0.0001).
Conclusions: In conclusion, the PK of bivalirudin was well characterized in Chinese
patients with a similar proﬁle to their Western counterparts (almost identical half-life
of 32 min in Chinese vs. 25 to 29 min in Caucasians). Rapid onset of effect was
observed with a signiﬁcant increase in the ACT within 5 minutes of bivalirudin
administration. In summary, PK/PD proﬁle of bivalirudin is predictable and consistent
across populations allowing extrapolation of clinical data.GW25-e2318
Inﬂuence of PGE1 on Contrast Media-Induced Renal Dysfunction in Coronary
Heart Disease combined with diabetic patients undergoing Coronary Artery
Intervention Therapy
Zhang Youming, Yu Zhuo
Department of Cardiology, First Afﬁliated Hospital of Kunming Medical University
Objectives: To study the effect of prostaglandin E1 on contrast media-induced renal
dysfunction in Coronary Heart Disease combined with diabetic patients undergoing
Coronary Artery Intervention Therapy.
Methods: 120 cases of Coronary Heart Disease combined with diabetic patients
were chose at the First Afﬁliated Hospital of Kunming Medical University from
march 2013 to march 2014 as research subjects, which had the coronary angiog-
raphy or percutaneous coronary artery stent implantation, coronary angiography
showed that at least one vessel stenosis in 50% and above. The patients were
randomly divided into group A (n¼60), group B (n¼60). Group A: normal control
group: conventional hydration. group B: Based on the conventional hydration and
received PGE1 (20ug) 30mins before operation, 8h,16h and 24h after oper-
ation,40ml saline diluted intravenous continuous infusion with 20ng/kg/min. All
patients’ blood urea nitrogen (BUN), serum cysteine inhibin (Cys-C), serum
creatinine (Scr) and b2 microglobulin (b2-MG) were measured before operation,
12h, 24h and 48h after operation. Evaluate glomerular ﬁltration rate (eGFR) was
caclulated according to the modiﬁed MDRD of Chinese population. The incidence
of CIN was analyzed.
Results: The baseline data and procedure features were not signiﬁcantly different
statistically among the three groups (P>0.05). There was no signiﬁcant difference in
BUN compared among and within the three groups (P>0.05). In group A atter
operation 12h, 24h, 48h, Scr ,Cys-C, b2-MG were higher compared to baseline
(P<0.05). In group B after operation 12h, 24h and 48h, Scr, Cys-C, and b2-MG were
higher compared to baseline (P<0.05), but was lower than group A after operation
12h and 24h. In group B, eGFR was higher than group A after operation 12h and 24h
(P<0.05).
Conclusions: (1) During perioperation period, contrast medium can induce renal
dysfunction in Coronary Heart Disease combined with diabetic patients. (2)
Coronary artery interventional therapy in Coronary Heart Disease combined with
diabetic patients with peroperation period and pretreatment with prostaglandin E1
can reduce acute renal function damage by contrast medium, improve glomerular
ﬁltration rate, and prevent contrast-induced nephropathy. (3) Independent risk
factors for CIN in patients with diabetes mellitus. (4) The hydration combined
with prostaglandin E1 was better than the hydration alone that can effectively
prevent the occurrence of CIN in Coronary Heart Disease combined with diabetic
patients.GW25-e2326
Cystatin C combined with creatinine seems to be a better early predictor of
CI-AKI in patients undergoing PCI
Shen Linghong, Ben He
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Objectives: A wide range of contrast-induced acute kidney injury (CI-AKI) rates
occurs after intervention between 3% and 30%, depending on the deﬁnition.
Recent studies demonstrated that serum cystatin C (CyC) strengthened the asso-
ciation between the eGFR and the risk of death and end-stage renal disease. In this
study, we investigated the prognostic impact of CyC alone or along with sCr on
patients undergoing PCI, and tried to ﬁnd a best cutoff of CyC for CI-AKI
detection.
Methods: We measured CyC together with sCr in 580 consecutive patients under-
going coronary angiography with or without percutaneous coronary intervention (PCI)
from July 2013 to February 2014 in our cardiovascular center. CyC and sCr wereJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cassessed at baseline and within 24 to 48 hours after contrast media exposure. Major
adverse coronary events (including all-cause mortality, myocardial infarction, and
cardiac revascularization) of 266 patients undergoing PCI were assessed during a
mean follow-up of 3.5 months.
Results: In 266 patients undergoing PCI, contrast-induced acute kidney injury
(deﬁned as a sCr increase 25%) occurred in 19 patients (7.14%) within 24 to 48 hours
after contrast media exposure. A CyC increase concentration 10%, 15%, 20% and
25% within 24 to 48 hours after contrast media exposure was detected in 49 patients
(18.42%), 35 patients (13.16%), 24 patients (9.02%) and 16 patients (6.02%),
respectively. By logistic regression analysis, the independent predictor of major
adverse events was cutoff deﬁned as increase in CyC 10% or sCr 25% (odds ratio3.89;
95% conﬁdence interval, 1.20 to 12.54; P¼0.02). The incidence of CI-AKI in 580
consecutive patients was 22.9% when deﬁned as this cutoff, and multivariable analysis
showed CKD (eGFR<60 mL/min/1.73 m2) was independent risk predictor for CI-
AKI (OR 3.96; 95% CI, 1.29 to 12.13; P<0.05). CI-AKI was seen not only in patients
with preserved renal function (eGFR > 60 mL/min/1.73 m2) but also in patients with
abnormal renal function (eGFR<60 mL/min/1.73 m2) when deﬁned as present cutoff.
However, CI-AKI could be only detected in patients with preserved renal function
when it was deﬁned as increase of sCr 25% within 24-48 hours after contrast medium
exposure. Preprocedural eGFR was 106.130.7 mL/min/1.73 m2 in patients with CI-
AKI deﬁned as present cutoff and was 129.531.2 mL/min/1.73 m2 in patients with
CI-AKI deﬁned as sCr 25% increasing (P<0.05). Postprocedural eGFR was
88.827.1 mL/min/1.73 m2 in patients with CI-AKI deﬁned as present cutoff and was
86.621.1 mL/min/1.73 m2 in patients with CI-AKI deﬁned as sCr 25% increasing (P
> 0.05). The comparison between preprocedural and postprocedural eGFR showed
that the decrease of renal function was 13.7 % in patients with CI-AKI deﬁned as
present cutoff and 31.1% n patients with CI-AKI deﬁned as sCr 25% increasing
(P<0.05).
Conclusions: In patients underwent CA or PCI, increase in CyC 10% or sCr 25%
within 24 to 48 hours after contrast media exposure seems to be a reliable marker for
the early diagnosis of CI-AKI. The higher sensitivity of the percent changes applies
not only to subjects with normal SC but also to patients with moderate or severe renal
damage. But increase of sCr is more likely to be seen in patients with normal or
moderate renal damage. Our data also suggest that Cystatin C combined with creat-
inine in patients underwent PCI is superior to 25% increase in sCr at identifying
patients at greater risk for adverse cardiac events.
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Objectives: Iatrogenic aortocoronary dissection is a rare but potentially disastrous
complication of percutaneous coronary intervention (PCI). However, there is a paucity
of data on the optimal initial management of this complication. The aim of this study
was to depict the characteristics and causes of iatrogenic aortocoronary dissection and
to elucidate the importance of a new strategy based on immediate bail-out stenting.
Methods: We collected 18 cases of iatrogenic aortocoronary dissection during PCI in
8 cardiac catheterization centers between 2005 and 2013, which were managed by a
single senior operator. A “4S” law based on immediate bail-out stenting performed
within 15 min was the initial strategy in most cases. The characteristics, treatment, and
in-hospital outcomes of the patients were evaluated.
Results: According to the NHLBI classiﬁcation, 15 patients (83.3%) had extensive
dissection (Type D to F) with acute closure (Type F) in 4 patients. In 3 patients
(16.7%), the dissections were diagnosed during coronary angiography, and in 15
patients (83.3%), during PCI. From the 18 patients, 16 patients (88.9%) underwent
bail-out stent implantation, with technical success in 14 patients. Among them, 13
patients followed the “4S” law, with 7.73.2 min from onset of dissection to
completion of bail-out stenting, and the procedural success rate was 100% with no
deaths. Two patients died due to time delay (stenting >15min) and the third one died
due to hemodynamic collapse because the guidewire failed to cross the true lumen.
Conclusions: This study indicated that the “4S” law based on immediate bail-out
stenting is a feasible and efﬁcient strategy for the management of iatrogenic aorto-
coronary dissection.
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Objectives: To investigate the inﬂuence of albuminuria on clinical outcomes in pa-
tients with type 2 diabetes mellitus (T2DM) after elective pecutaneous coronary
intervention.ardiovascular Disease Clinical Research C145
